Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

U.S. Alzheimer's Disease Medication Markets

U.S. Alzheimer's Disease Medication Markets

 

RELEASE DATE
31-May-2007
REGION
North America
Research Code: N092-01-00-00-00
SKU: HC02004-NA-MR_07294
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02004-NA-MR_07294

$4,950.00

$3,712.50save 25 %

DownloadLink
Add to Compare
ENQUIRE NOW

Description

The U.S. Alzheimer's disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail marketed products, revenue forecasts, product pipeline and competitive structure.

Table of Contents

Executive Summary

  • Introduction

Research Scope and Segmentation

  • Scope and Segmentation
  • Research Methodology

Disease Overview and Treatment Options

  • Disease Overview
  • Disease Progression
  • Disease Causes and Risk Factors
  • Disease Burden
  • Diagnosis
  • Treatment Overview

Total Market Introduction

  • Introduction
  • Competitive Structure
  • Market Engineering Measurements
  • Unmet Needs in the Alzheimer's Disease Medication Market
  • Patient Forecasts
  • Revenue Forecasts
  • Market Share Analysis

General Market Trends

  • Industry Challenges
  • Market Drivers
  • Market Restraints

Strategies for Growth

  • Strategic Recommendations

Market Overview

Product Analysis

Market Forecasts

Market Overview

Product Analysis

Market Forecasts

Overview

Market Forecasts

Decision Support Database

Request Sample
Popular Topics

silicone market

fuel cell market

commercial lighting market

smart meter market

biocides market

food waste market

agricultural drones market

3d printer market share

activated carbon market

nutritional supplement market

The U.S. Alzheimer's disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail marketed products, revenue forecasts, product pipeline and competitive structure.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number N092-01-00-00-00
Is Prebook No